Insung Yong

Mr. Insung Yong

Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2023 in eLife
Verified
Journal Article
Open access
MAMark Borris D Aldonza
Mark Borris D Aldonza
JCJunghwa Cha
Junghwa Cha
IYInsung Yong
Insung Yong
JKJayoung Ku
Jayoung Ku
PSPavel Sinitcyn
Pavel Sinitcyn
YKYoosik Kim
Yoosik Kim
Cancer secretome is a reservoir for aberrant glycosylation. How therapies alter this post- translational cancer hallmark and the consequences thereof remain elusive. Here, we show that an elevated secretome fucosylation is a pan-cancer signature of both response and resistance to multiple targeted therapies. Large-scale pharmacogenomics revealed that fucosylation genes display widespread association with resistance to these therapies. In cancer cell cultures, xenograft mouse models, and patients, targeted kinase inhibitors distinctively induced core fucosylation of secreted proteins less than 60 kDa. Label-free proteomics of N-glycoproteomes identified fucosylation of the antioxidant PON1 as a critical component of the therapy-induced secretome (TIS). N-glycosylation of TIS and target core fucosylation of PON1 are mediated by the fucose salvage-FUT8-SLC35C1 axis with PON3 directly modulating GDP-Fuc transfer on PON1 scaffolds. Core fucosylation in the Golgi impacts PON1 stability and folding prior to secretion, promoting a more degradation-resistant PON1. Global and PON1-specific secretome de-N-glycosylation both limited the expansion of resistant clones in a tumor regression model. We defined the resistance-associated transcription factors (TFs) and genes modulated by the N-glycosylated TIS via a focused and transcriptome-wide analyses. These genes characterize the oxidative stress, inflammatory niche, and unfolded protein response as important factors for this modulation. Our findings demonstrate that core fucosylation is a common modification indirectly induced by targeted therapies that paradoxically promotes resistance.

23 May 2024 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
HCHeewon Cho
Heewon Cho
NHNa-Kyeong Hong
Na-Kyeong Hong
IYInsung Yong
Insung Yong
HKHaw-Young Kwon
Haw-Young Kwon
NKNam-Young Kang
Nam-Young Kang
YCYoung-Tae Chang
Young-Tae Chang
A novel fluorescent probe, AGO, systematically detects advanced glycation end products involved in aging.

30 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
JCJunghwa Cha
Junghwa Cha
WSWoogwang Sim
Woogwang Sim
IYInsung Yong
Insung Yong
JPJunseong Park
Junseong Park
JSJin-Kyoung Shim
Jin-Kyoung Shim
PKPilhan Kim
Pilhan Kim
Phenotypic heterogeneity of glioblastomas is a leading determinant of therapeutic resistance and treatment failure. However, functional assessment of the heterogeneity of glioblastomas is lacking. We developed a self-assembly-based assessment system that predicts inter/intracellular heterogeneity and phenotype associations, such as cell proliferation, invasiveness, drug responses, and gene expression profiles. Under physical constraints for cellular interactions, mixed populations of glioblastoma cells are sorted to form a segregated architecture, depending on their preference for binding to cells of the same phenotype. Cells distributed at the periphery exhibit a reduced temozolomide (TMZ) response and are associated with poor patient survival, whereas cells in the core of the aggregates exhibit a significant response to TMZ. Our results suggest that the multicellular self-assembly pattern is indicative of the intertumoral and intra-patient heterogeneity of glioblastomas, and is predictive of the therapeutic response.

28 February 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
HCHeewon Cho
Heewon Cho
NHNa-Kyeong Hong
Na-Kyeong Hong
IYInsung Yong
Insung Yong
HKHaw-Young Kwon
Haw-Young Kwon
NKNam-Young Kang
Nam-Young Kang
YCYoung-Tae Chang
Young-Tae Chang
Advanced glycation end products (AGEs) play a significant role in the aging processes, further regarding as a hallmark of aging. Despite the importance, a lack of monitoring tools has hampered the study of relationship between AGEs and aging. Here, we firstly report a novel AGEs-selective probe, AGO. AGO presented its ability to detect AGEs more sensitively than a conventional approach of measuring autofluorescence from AGEs. In addition, we confirmed that AGO can detect AGEs depending on kinetics, reflecting by a preference to ribose-derived AGEs. Finally, AGO revealed its competence to visualize glycation products in glycation mimicking model, made by collagen framework. We believe that this study will enrich molecular toolboxes to understand physiological processes of AGEs during aging processes.